Company / Operating Margin
Axsome Therapeutics, Inc. Operating Margin History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-26.1%
FY2025
5-year range
-85.7% / -26.1%
FY2023-FY2025
Trend
+64.1%
vs FY2024
Sector context
#69 of 136
Health Care
What the data says
At -26.1%, Axsome Therapeutics, Inc.'s operating margin ranks #69 of 136 in the Health Care sector. Improved from -85.7% to -26.1% over the past 2 years.
Based on SEC 10-K filings.
-26.1% in FY2025.
Improved from -85.7% to -26.1% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#69 of 136 in Health CareTop 51% of 136This company -26.1% Sector average -778.9%
▼
+96.6% above sector average
Key checks
Key Insights
- In FY2025, operating margin increased 64.1% year-over-year.
- Currently 752.8pp above the Health Care sector average.
Company context
Key Data Points
- Altman Z-Score -1.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -26.1% | +64.1% |
| FY2024 | -72.7% | +15.1% |
| FY2023 | -85.7% | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026